Covered recipient · General Payments record
DEBRA L RODGERS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,217.31
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $666.38 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $236.09 | 2 |
| Novo Nordisk AS | $179.44 | 4 |
| ABBVIE INC. | $150.88 | 5 |
| Merck Sharp & Dohme Corporation | $50.57 | 3 |
| Hologic Sales and Service, LLC | $22.12 | 1 |
| Sumitomo Pharma America, Inc. | $14.14 | 1 |
| Corcept Therapeutics | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.74 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108102136 | CMS |
| ABBVIE INC. | $11.62 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108102138 | CMS |
| ABBVIE INC. | $13.82 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108102140 | CMS |
| ABBVIE INC. | $115.60 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108102142 | CMS |
| ABBVIE INC. | $4.10 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108102144 | CMS |
| Corcept Therapeutics | $13.14 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117770146 | CMS |
| Hologic Sales and Service, LLC | $22.12 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084911118 | CMS |
| Lilly USA, LLC | $124.99 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135606943 | CMS |
| Lilly USA, LLC | $111.10 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135607593 | CMS |
| Merck Sharp & Dohme LLC | $18.94 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141960928 | CMS |
| Merck Sharp & Dohme LLC | $16.92 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141985137 | CMS |
| Merck Sharp & Dohme LLC | $14.71 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141734595 | CMS |
| Novo Nordisk Inc | $16.51 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100342768 | CMS |
| Novo Nordisk Inc | $22.59 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100374105 | CMS |
| Novo Nordisk Inc | $124.99 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100603176 | CMS |
| Novo Nordisk Inc | $15.35 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100283344 | CMS |
| Sumitomo Pharma America, Inc. | $14.14 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148991291 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.